C
Cheryl M. Coffin
Researcher at Vanderbilt University
Publications - 118
Citations - 10436
Cheryl M. Coffin is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Sarcoma & Rhabdomyosarcoma. The author has an hindex of 42, co-authored 117 publications receiving 9701 citations. Previous affiliations of Cheryl M. Coffin include Vanderbilt University Medical Center & University of Utah.
Papers
More filters
Journal ArticleDOI
Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 Cases
TL;DR: In this paper, the authors report their experience with 84 cases occurring in the soft tissues and viscera of 48 female patients and 36 male patients between the ages of 3 months and 46 years (mean, 9.7 years; median, 9 years).
Journal ArticleDOI
Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.
TL;DR: A subset of IMTs with histologic atypia and/or clinical aggressiveness that were analyzed for clinicopathologic features, outcome, and immunohistochemical expression of anaplastic lymphoma kinase (ALK) and other markers to identify potential pathologic prognostic features found ALK reactivity may be a favorable prognostic indicator in IMT and abdominopelvic IMTs recur more frequently.
Journal ArticleDOI
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.
Cheryl M. Coffin,Ankita S. Patel,Sherrie L. Perkins,Kojo S.J. Elenitoba-Johnson,Elizabeth J. Perlman,Constance A. Griffin +5 more
TL;DR: Abnormalities of ALK and p80 and evidence of chromosomal rearrangements of 2p23 occur in a significant proportion of IMTs and suggest that aneuploid IMT is a subset with more aggressive clinical behavior.
Journal ArticleDOI
Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
James R. Cook,Louis P. Dehner,Margaret H. Collins,Zhigui Ma,Stephan W. Morris,Cheryl M. Coffin,D. Hill +6 more
TL;DR: Anti-ALK staining seems to correlate with those IMTs that have the typical tri-patterned histologic appearance and clinical presentation, providing additional support to the premise that IMT is a distinctive clinicopathologic entity within the broad category of inflammatory pseudotumors.
Journal ArticleDOI
Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
Samuel A. Wells,David Chi,Koji Toshima,Louis P. Dehner,Cheryl M. Coffin,S. Bruce Dowton,Jennifer Ivanovich,Mary K. DeBenedettl,William G. Dilley,Jeffrey F. Moley,Jeffrey F. Moley,Jeffrey A. Norton,Helen Donis-Keller +12 more
TL;DR: The direct test for mutations in the RET protooncogene is the preferred method for screening MEN 2A kindreds and in family members who have inherited a RET mutation, total thyroidectomy is indicated, regardless of the plasma CT values.